The Goldman Sachs Group, Inc. 13D and 13G filings for Biotech Acquisition Company:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 10:50 am Sale | 2022-12-30 | 13G | Biotech Acquisition Company BIOT | GOLDMAN SACHS GROUP INC GS | 250,525 1.100% | -944,153 (-79.03%) | Filing |
| 2023-02-13 5:21 pm Purchase | 2022-12-30 | 13G | Biotech Acquisition Company BIOT | GOLDMAN SACHS GROUP INC GS | 250,525 1.100% | 250,525 (New Position) | Filing |
| 2022-02-10 12:29 pm Purchase | 2021-12-31 | 13G | Biotech Acquisition Company BIOT | GOLDMAN SACHS GROUP INC GS | 1,194,678 5.200% | 1,194,678 (New Position) | Filing |